SARS-CoV-2 immune complex triggers human monocyte necroptosis

Int Immunopharmacol. 2023 Apr:117:109954. doi: 10.1016/j.intimp.2023.109954. Epub 2023 Feb 27.

Abstract

We analyzed the ability of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) itself and SARS-CoV-2-IgG immune complexes to trigger human monocyte necroptosis. SARS-CoV-2 was able to induce monocyte necroptosis dependently of MLKL activation. Necroptosis-associated proteins (RIPK1, RIPK3 and MLKL) were involved in SARS-CoV-2N1 gene expression in monocytes. SARS-CoV-2 immune complexes promoted monocyte necroptosis in a RIPK3- and MLKL-dependent manner, and Syk tyrosine kinase was necessary for SARS-CoV-2 immune complex-induced monocyte necroptosis, indicating the involvement of Fcγ receptors on necroptosis. Finally, we provide evidence that elevated LDH levels as a marker of lytic cell death are associated with COVID-19 pathogenesis.

Keywords: COVD-19 pathogenesis; Fcγ receptors; MLKL; Monocyte; Necroptosis; SARS-CoV-2.

MeSH terms

  • Antigen-Antibody Complex* / metabolism
  • COVID-19*
  • Humans
  • Monocytes
  • Necroptosis
  • Protein Kinases / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases / genetics
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism
  • SARS-CoV-2

Substances

  • Antigen-Antibody Complex
  • Protein Kinases
  • Receptor-Interacting Protein Serine-Threonine Kinases